ATAD2 and neoplasm: Elevated levels of ATAD2 expression correlate with unfavorable patient prognosis in colorectoral4, lung1, and breast cancer5, and knockdown of ATAD2 has been demonstrated to inhibit tumor proliferation and invasiveness6.